UBS Downgrades FMC to Neutral, Lowers Price Target to $97
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Joshua Spector has downgraded FMC (NYSE:FMC) from Buy to Neutral and lowered the price target from $120 to $97.
September 05, 2023 | 9:20 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
FMC has been downgraded from Buy to Neutral by UBS, with a lowered price target of $97.
The downgrade from Buy to Neutral by UBS indicates a less optimistic outlook for FMC. The lowering of the price target from $120 to $97 also suggests that UBS sees less upside potential in the stock, which could negatively impact its short-term price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100